Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2011
10/11/2011CA2468258C Peptide agonists of prostate-specific antigen, and uses therefor
10/11/2011CA2465327C Nonhuman model animal of th2-mediated hyperimmune response
10/11/2011CA2442993C Nucleic acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/11/2011CA2430314C Gene encoding acetolactate synthase
10/11/2011CA2363971C A method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus
10/11/2011CA2362658C In vitro production of transplantable cartilage tissue
10/11/2011CA2362098C Human polyclonal antibodies from genetically engineered animals
10/11/2011CA2336743C Antigenic peptides derived from telomerase
10/11/2011CA2315017C Novel egiii-like enzymes, dna encoding such enzymes and methods for producing such enzymes
10/11/2011CA2157932C Production of human papillomavirus capsid protein and virus-like particles
10/06/2011WO2011123779A1 Cell therapy to improve wound healing and related compositions and methods
10/06/2011WO2011123708A2 Genetic engineering of non-human animals for the production of chimeric antibodies
10/06/2011WO2011123572A1 Reprogramming cells
10/06/2011WO2011123213A1 Methods of multiplying plant embryogenic tissue in a bioreactor
10/06/2011WO2011123166A2 Methods and systems for reducing dna fragmentation in a processed sperm sample
10/06/2011WO2011123038A1 Method for maturing and synchronizing conifer somatic embryos.
10/06/2011WO2011122889A2 Method for inhibiting the senescence of adult stem cells by inhibiting mirna expression
10/06/2011WO2011122611A1 Cancer vaccine
10/06/2011WO2011122601A1 Intervertebral disc nucleus pulposus stem/progenitor cell, method for culturing same, and application
10/06/2011WO2011122318A1 Therapeutic graft material and method for using same
10/06/2011WO2011122127A1 Peptide having osteoblast proliferation promotion activity and use thereof
10/06/2011WO2011121768A1 Novel cellulase gene
10/06/2011WO2011121636A1 Method for producing induced pluripotent stem cells
10/06/2011WO2011121158A2 Method for obtaining oligodendrocyte precursor cells
10/06/2011WO2011096894A3 Use of novel markers of pluripotent stem cells
10/06/2011WO2011063005A3 Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells
10/06/2011US20110247105 Osteospermum and dimorphoteca plants having an altered flower phenotype
10/06/2011US20110247104 Homologous recombination-mediated transgene deletion in plant cells
10/06/2011US20110247103 Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing
10/06/2011US20110247102 Constitutive promoters from poplar and uses thereof
10/06/2011US20110247101 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
10/06/2011US20110247100 Plant peptide gamma-zein for delivery of biomolecules into plant cells
10/06/2011US20110247099 Genetic transformation of jatropha curcas
10/06/2011US20110247098 Plants Having Enhanced Abiotic Stress Tolerance and/or Enhanced Yield-Related Traits and a Method for Making the Same
10/06/2011US20110247097 Plants having modified growth characteristics and a method for making the same
10/06/2011US20110247094 Transgenic Plants with Enhanced Agronomic Traits
10/06/2011US20110247092 Osteospermum and dimorphoteca plants having an altered flower phenotype
10/06/2011US20110247091 Transgenic Cells and Chickens Expressing RIG-I
10/06/2011US20110247090 Synthetic 5'UTRs, Expression Vectors, and Methods for Increasing Transgene Expression
10/06/2011US20110247088 Tetracycline inducible transcription control sequence
10/06/2011US20110247087 Regulation of endogenous gene expression in cells using zinc finger proteins
10/06/2011US20110245470 Immunoglobulins
10/06/2011US20110245351 Medical adhesive for surgery
10/06/2011US20110245329 Double-stranded rna structures and constructs, and methods for generating and using the same
10/06/2011US20110245325 Pharmaceutical composition for treatment of cancer and asthma
10/06/2011US20110245318 Rna sequence-specific mediators of rna interference
10/06/2011US20110245311 Histidine Derivatives
10/06/2011US20110245307 Methods for Alzheimer's Disease Treatment and Cognitive Enhancement
10/06/2011US20110245251 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
10/06/2011US20110245220 Compounds and compositions as modulators of gpr119 activity
10/06/2011US20110245217 Methods for diagnosing and treating asthma
10/06/2011US20110245207 Method for moderately increasing the proton conductivity of biological membranes with the aid of mitochondria-targeted delocalized cations
10/06/2011US20110245186 Recombinant e-selectin made in insect cells
10/06/2011US20110245185 APO-2 ligand/trail formulations
10/06/2011US20110245178 Exendin Fusion Proteins
10/06/2011US20110245175 INHIBITING INTERACTION BETWEEN THE HIF-1ALPHA AND p300/CBP WITH HYDROGEN BOND SURROGATE-BASED
10/06/2011US20110245168 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
10/06/2011US20110245167 NaK-ATPase-Derived Peptide SRC Inhibitors and Ouabain Antagonists and Uses Thereof
10/06/2011US20110245107 Selective differentiation, identification, amd modulation of human th17 cells
10/06/2011US20110244574 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
10/06/2011US20110244573 Method For The Supply Of Growth Components To Cell Cultures
10/06/2011US20110244572 Flat microfibers as matrices for cell growth
10/06/2011US20110244571 Cell growth
10/06/2011US20110244570 Volume exclusion agent to enhance formation of extracellular matrix
10/06/2011US20110244569 Method of inducing proliferation and/or differentiation of neural precursor cells by introducing prolactin or wnt3a to activate latent neural precursor cells
10/06/2011US20110244568 Rna sequence-specific mediators of rna interference
10/06/2011US20110244567 Device and Method of 3-Dimensionally Generating IN VITRO Blood Vessels
10/06/2011US20110244566 Enhanced efficiency of induced pluripotent stem cell generation
10/06/2011US20110244565 Method Of Collecting Particles From A Sample Fluid
10/06/2011US20110244564 Cystine knot molecules
10/06/2011US20110244563 Assays that use the t1r1 receptor polypeptides to screen for t1r1-associated taste modulators
10/06/2011US20110244562 Rna interference suppression of neurodegenerative diseases and methods of use thereof
10/06/2011US20110244561 siRNA-MEDIATED GENE SILENCING
10/06/2011US20110244548 DNA Polymerases Having Improved Labeled Nucleotide Incorporation Properties
10/06/2011US20110244514 Mammalian Sweet Taste Receptors
10/06/2011US20110244513 Isolated mammalian membrane protein genes; related reagents
10/06/2011US20110244507 USE OF NEUREGULIN-ß AS AN INDICATOR AND/OR TARGET
10/06/2011US20110244502 Hormone responsive tissue culture system and uses thereof
10/06/2011US20110244501 Cancer stem cells
10/06/2011US20110244496 Hiv reverse transcriptase compositions and methods
10/06/2011US20110244487 Methods for testing binding of a ligand to a g protein-coupled receptor
10/06/2011US20110244485 Anti-tuna vasa antibody
10/06/2011US20110244474 Rapid screening of biologically active nucleases and isolation of nuclease-modified cells
10/06/2011US20110244472 Cancer stem cell immortalization
10/06/2011US20110244470 Isolated transgenic mammalian neural cell for detection of a sample containing a chemical substance damage to neurological system or selection of drugs for treating neurodegenerative disorders
10/06/2011US20110244450 Primate totipotent and pluripotent stem cells produced by somatic cell nuclear transfer
10/06/2011US20110244446 Rna sequence-specific mediators of rna interference
10/06/2011US20110244443 Methods, Systems and Devices for Separating Tumor Cells
10/06/2011US20110244025 Modified oligoribonucleotide analogs with enhanced immunostimulatory activity
10/06/2011US20110244003 Self Standing Nanoparticle Networks/Scaffolds with Controllable Void Dimensions
10/06/2011US20110243995 Method for Rational Mutagenesis of Alpha/Beta T-Cell Receptors and Correspondingly Mutated MDM2-Protein Specific Alpha/Beta T-Cell Receptors
10/06/2011US20110243986 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use
10/06/2011US20110243973 Hig2 and urlc10 epitope peptide and vaccines containing the same
10/06/2011US20110243968 Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
10/06/2011US20110243967 Molecular complexes which modify immune responses
10/06/2011US20110243966 SINGLE CHAIN Fc (ScFc) REGIONS, BINDING POLYPEPTIDES COMPRISING SAME, AND METHODS RELATED THERETO
10/06/2011US20110243965 Antibodies against domains of laminin-332
10/06/2011US20110243963 Antibodies to lrp6
10/06/2011US20110243962 Therapeutic use of specific ligand in msrv associated diseases
10/06/2011US20110243957 Materials and methods for preventing or treating neurodegenerative conditions associated with abeta peptide accumulation